Cargando…
Efficacy and safety of intensity-modulated radiation therapy versus three-dimensional conformal radiation treatment for patients with gastric cancer: a systematic review and meta-analysis
BACKGROUND: Radiation or radiochemotherapy is a common adjuvant therapy for gastric cancer. Intensity-modulated radiation therapy (IMRT) has been demonstrated to provide better dose conformity, allowing dose escalation and/or reduction of normal tissue exposure compared with three-dimensional confor...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532249/ https://www.ncbi.nlm.nih.gov/pubmed/31118042 http://dx.doi.org/10.1186/s13014-019-1294-0 |
_version_ | 1783420983403610112 |
---|---|
author | Ren, Fang Li, Shaodan Zhang, Yin Zhao, Zhifei Wang, Haiming Cui, Yixin Wang, Maoyun |
author_facet | Ren, Fang Li, Shaodan Zhang, Yin Zhao, Zhifei Wang, Haiming Cui, Yixin Wang, Maoyun |
author_sort | Ren, Fang |
collection | PubMed |
description | BACKGROUND: Radiation or radiochemotherapy is a common adjuvant therapy for gastric cancer. Intensity-modulated radiation therapy (IMRT) has been demonstrated to provide better dose conformity, allowing dose escalation and/or reduction of normal tissue exposure compared with three-dimensional conformal radiation treatment (3D-CRT). However, the efficacy of IMRT and 3D-CRT in gastric cancer remains controversial. This study aimed to compare the efficacy and safety of IMRT with those of 3D-CRT in treating patients with gastric cancer through conducting a meta-analysis of 3-year survival rates [overall survival (OS) and disease-free survival (DFS)], local control rates, and toxic event rates. METHODS: Embase, PubMed, the Cochrane Library, and clinical trial databases were searched to identify the clinical trials of IMRT versus 3D-CRT for treating patients with gastric cancer. The obtained data of survival and safety were analyzed using the Stata 14.0 software. RESULTS: A total of 9 controlled clinical studies, including 516 patients with gastric cancer, met the inclusion criteria and were included in this meta-analysis. The results of the meta-analysis showed that the 3-year OS rate was slightly higher in the IMRT group than in the 3D-CRT group, without any statistical significance. The 3-year local control rate was significantly higher in the IMRT group than in the 3D-CRT group. No significant difference in the 3-year DFS rate was found between the IMRT and 3D-CRT groups. Grade 2–4 toxicities were similar between the IMRT and 3D-CRT groups. CONCLUSION: The findings suggested that IMRT might be superior to 3D-CRT in treating patients with gastric cancer in terms of local control rates without increasing toxicity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13014-019-1294-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6532249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65322492019-05-29 Efficacy and safety of intensity-modulated radiation therapy versus three-dimensional conformal radiation treatment for patients with gastric cancer: a systematic review and meta-analysis Ren, Fang Li, Shaodan Zhang, Yin Zhao, Zhifei Wang, Haiming Cui, Yixin Wang, Maoyun Radiat Oncol Review BACKGROUND: Radiation or radiochemotherapy is a common adjuvant therapy for gastric cancer. Intensity-modulated radiation therapy (IMRT) has been demonstrated to provide better dose conformity, allowing dose escalation and/or reduction of normal tissue exposure compared with three-dimensional conformal radiation treatment (3D-CRT). However, the efficacy of IMRT and 3D-CRT in gastric cancer remains controversial. This study aimed to compare the efficacy and safety of IMRT with those of 3D-CRT in treating patients with gastric cancer through conducting a meta-analysis of 3-year survival rates [overall survival (OS) and disease-free survival (DFS)], local control rates, and toxic event rates. METHODS: Embase, PubMed, the Cochrane Library, and clinical trial databases were searched to identify the clinical trials of IMRT versus 3D-CRT for treating patients with gastric cancer. The obtained data of survival and safety were analyzed using the Stata 14.0 software. RESULTS: A total of 9 controlled clinical studies, including 516 patients with gastric cancer, met the inclusion criteria and were included in this meta-analysis. The results of the meta-analysis showed that the 3-year OS rate was slightly higher in the IMRT group than in the 3D-CRT group, without any statistical significance. The 3-year local control rate was significantly higher in the IMRT group than in the 3D-CRT group. No significant difference in the 3-year DFS rate was found between the IMRT and 3D-CRT groups. Grade 2–4 toxicities were similar between the IMRT and 3D-CRT groups. CONCLUSION: The findings suggested that IMRT might be superior to 3D-CRT in treating patients with gastric cancer in terms of local control rates without increasing toxicity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13014-019-1294-0) contains supplementary material, which is available to authorized users. BioMed Central 2019-05-22 /pmc/articles/PMC6532249/ /pubmed/31118042 http://dx.doi.org/10.1186/s13014-019-1294-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Ren, Fang Li, Shaodan Zhang, Yin Zhao, Zhifei Wang, Haiming Cui, Yixin Wang, Maoyun Efficacy and safety of intensity-modulated radiation therapy versus three-dimensional conformal radiation treatment for patients with gastric cancer: a systematic review and meta-analysis |
title | Efficacy and safety of intensity-modulated radiation therapy versus three-dimensional conformal radiation treatment for patients with gastric cancer: a systematic review and meta-analysis |
title_full | Efficacy and safety of intensity-modulated radiation therapy versus three-dimensional conformal radiation treatment for patients with gastric cancer: a systematic review and meta-analysis |
title_fullStr | Efficacy and safety of intensity-modulated radiation therapy versus three-dimensional conformal radiation treatment for patients with gastric cancer: a systematic review and meta-analysis |
title_full_unstemmed | Efficacy and safety of intensity-modulated radiation therapy versus three-dimensional conformal radiation treatment for patients with gastric cancer: a systematic review and meta-analysis |
title_short | Efficacy and safety of intensity-modulated radiation therapy versus three-dimensional conformal radiation treatment for patients with gastric cancer: a systematic review and meta-analysis |
title_sort | efficacy and safety of intensity-modulated radiation therapy versus three-dimensional conformal radiation treatment for patients with gastric cancer: a systematic review and meta-analysis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532249/ https://www.ncbi.nlm.nih.gov/pubmed/31118042 http://dx.doi.org/10.1186/s13014-019-1294-0 |
work_keys_str_mv | AT renfang efficacyandsafetyofintensitymodulatedradiationtherapyversusthreedimensionalconformalradiationtreatmentforpatientswithgastriccancerasystematicreviewandmetaanalysis AT lishaodan efficacyandsafetyofintensitymodulatedradiationtherapyversusthreedimensionalconformalradiationtreatmentforpatientswithgastriccancerasystematicreviewandmetaanalysis AT zhangyin efficacyandsafetyofintensitymodulatedradiationtherapyversusthreedimensionalconformalradiationtreatmentforpatientswithgastriccancerasystematicreviewandmetaanalysis AT zhaozhifei efficacyandsafetyofintensitymodulatedradiationtherapyversusthreedimensionalconformalradiationtreatmentforpatientswithgastriccancerasystematicreviewandmetaanalysis AT wanghaiming efficacyandsafetyofintensitymodulatedradiationtherapyversusthreedimensionalconformalradiationtreatmentforpatientswithgastriccancerasystematicreviewandmetaanalysis AT cuiyixin efficacyandsafetyofintensitymodulatedradiationtherapyversusthreedimensionalconformalradiationtreatmentforpatientswithgastriccancerasystematicreviewandmetaanalysis AT wangmaoyun efficacyandsafetyofintensitymodulatedradiationtherapyversusthreedimensionalconformalradiationtreatmentforpatientswithgastriccancerasystematicreviewandmetaanalysis |